Sirolimus Early Treatment in Vascular Anomalies Leads to a Better Response
Objectives:. Sirolimus has become a relevant drug in the treatment of vascular anomalies, initially relegated to rescue therapy for refractory lesions but more recently has become first line. Our objective is to determine when it is best to start sirolimus treatment. Methods:. A retrospective review...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health/LWW
2023-03-01
|
| Series: | Journal of Vascular Anomalies |
| Online Access: | http://journals.lww.com/10.1097/JOVA.0000000000000065 |